Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial.

Clinical trial NCT05748561 · UNKNOWN

Trial details

NCT number: NCT05748561
Sponsor: Asociación para Evitar la Ceguera en México
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Toxic Optic Neuropathy Treatment Methylprednisolone Erythropoietin

Start date: 2022-04-05
Primary completion: 2024-04-05
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.